Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

8 Aug 2008 07:00

RNS Number : 9193A
Avon Rubber PLC
08 August 2008
 



 8th August 2008

AVON RUBBER p.l.c.

("Avon", the "Group" or the "Company")

Interim Management Statement for the period from 31 March 2008 to 7 August 2008

In the interim results announced on 28 May 2008, the Company stated that the award of the multi-year respirator contract by the US Department of Defense (DoD) and the expectation of securing long-term contracts for the Engineered Fabrications business, should underpin the Group's return to profitability in the short-term. It was further explained that difficulties had been experienced in the production of filters for the M50 respirator, which had led to delays and cost overruns. 

Avon has now commenced delivery to schedule of mask systems against the DoD order, but has experienced continuing start up production issues relating to these complex new filters which will restrict our ability to deliver accelerated quantities of systems this financial year. Avon is confident that measures have been implemented to resolve these issues. However, production costs, as a consequence, will be higher in the current financial year.

The Company is also pleased to announce that the DoD has exercised a requirements option under our contract which allows theto order total quantities of up to 300,000 mask systems per year for a period of up to 10 years. Orders of $17are expected to be placed under this contract for delivery next year in addition to the $22m already on order.

Delays in the award of a multi-year Government contract to our US based Engineered Fabrications business will reduce its revenue this financial year. The Company remains confident that this contract will be in place for 2009. At Avon-ISI, the improved levels of enquiries and orders experienced towards the end of the first half have not been maintained, largely due to aggressive market pricing by competitors. We are taking actions to manage this situation. 

Net debt increased to £18.3m at 30 June 2008 (31 March 2008: £13.5m) due to costs associated with the closure of the mixing plant and a further increase in working capital associated with the DoD contract. 

The excellent performance from the Dairy business has continued. The Company believes that the Protection and Defense business with its range of new products, the orders currently in hand and the future opportunities arising from our unique market position will deliver significantly enhanced future performance. 

Peter Slabbert, recently appointed as Chief Executive, commented:

"We have strengthened the management team with the appointment of Andrew Lewis as Group Finance Director and Matthew Evans from BAE Systems, as Rest of World Sales and Marketing Director within the Protection business and we are actively pursuing all opportunities for returning the Group to profitability."

END >

For further enquiries please contact: 

Avon Rubber p.l.c:

Peter Slabbert  01225 896883

Weber Shandwick Financial:

Richard Hews

Rachel Martin 020 7067 0700

Hannah Marwood

NOTES TO EDITORS:

Avon Rubber p.l.c. is an international polymer engineering group adding value through material, manufacturing and industry sector expertise. For further information please visit the Group's website www.avon-rubber.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSWFMWSASEEA
Date   Source Headline
18th Dec 201710:18 amRNSNotice of Annual Report and Accounts and AGM
6th Dec 20173:39 pmRNSDirector/PDMR Shareholding
6th Dec 20172:14 pmRNSDirector/PDMR Shareholding
6th Dec 20177:00 amRNSUS Department of Defense Mask Systems Order
30th Nov 20174:20 pmRNSDirector/PDMR Shareholding
29th Nov 201711:10 amRNSDirector/PDMR Shareholding
24th Nov 20174:39 pmRNSDirector/PDMR Shareholding
15th Nov 20177:00 amRNSFinal Results
8th Nov 20177:00 amRNSAward of US JE-RDAP CBRNe framework contract
7th Nov 201712:15 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:30 pmRNSPreferred bidder nomination
6th Oct 20173:42 pmRNSDirector/PDMR Shareholding
20th Sep 20175:01 pmRNSHolding(s) in Company
15th Sep 20177:00 amRNSPre-close trading update
12th Sep 20179:13 amRNSDirector/PDMR Shareholding
8th Sep 20179:07 amRNSDirector/PDMR Shareholding
4th Sep 201711:06 amRNSHolding(s) in Company
31st Aug 20174:08 pmRNSDirector/PDMR Shareholding
21st Aug 20172:06 pmRNSHolding(s) in Company
21st Aug 20171:53 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAppointment of Corporate Broker
14th Aug 20179:59 amRNSDirector/PDMR Shareholding
9th Aug 201710:16 amRNSDirector/PDMR Shareholding
8th Aug 20173:33 pmRNSDirector/PDMR Shareholding
8th Aug 20171:23 pmRNSHolding(s) in Company
31st Jul 201711:03 amRNSDirector/PDMR Shareholding
6th Jul 20171:18 pmRNSDirectors'/PDMR Shareholdings - SIP
6th Jun 201711:51 amRNSDirector/PDMR Shareholding
23rd May 20177:00 amRNSContract Award
16th May 20177:00 amRNSHalf-year Report
10th May 20177:00 amRNSDirectorate Change
8th May 201712:31 pmRNSDirector/PDMR Shareholding
6th Apr 20174:03 pmRNSDirector/PDMR Shareholding
7th Mar 201710:34 amRNSDirector/PDMR Shareholding
17th Feb 20175:45 pmRNSHolding(s) in Company
15th Feb 20172:34 pmRNSDirector/PDMR Shareholding
15th Feb 20177:00 amRNSDirectorate Change
8th Feb 20174:11 pmRNSDirector/PDMR Shareholding
3rd Feb 20175:22 pmRNSHolding(s) in Company
2nd Feb 20175:13 pmRNSResult of AGM
2nd Feb 20177:00 amRNSTrading Update
26th Jan 20179:37 amRNSHolding(s) in Company
9th Jan 201710:20 amRNSDirector/PDMR Shareholding
3rd Jan 201710:14 amRNSHolding(s) in Company
20th Dec 20168:52 amRNSHolding(s) in Company
9th Dec 201610:43 amRNSDirector/PDMR Shareholding
9th Dec 201610:42 amRNSAnnual Report and Financial Statements 2015
7th Dec 20164:07 pmRNSDirector/PDMR Shareholding
5th Dec 20163:24 pmRNSDirector/PDMR Shareholding
1st Dec 201612:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.